#RiskBasedMonitoring

[zenovel]

Revolutionizing Clinical Trial Monitoring with Risk-Based Strategies

At Zenovel, we redefine clinical trial monitoring with our innovative Risk-Based Monitoring (RBM) approach. Unlike traditional methods, RBM focuses on high-risk areas, optimizing resources and enhancing data integrity, participant safety, and regulatory compliance. Our expert clinical monitors use a blend of centralized monitoring and targeted on-site visits to identify risks early and ensure trial success. With Zenovel’s RBM solutions, sponsors achieve faster timelines, cost savings, and high-quality outcomes. Let us help you transform your clinical trials with precision and efficiency.

[sharvaricmi]

Risk-Based Monitoring Market Global Company Analysis By Size, Share, Trends, Company Overview and Forecast 2019 - 2027

Risk-based monitoring is the process of ensuring the quality of clinical trials by identifying, assessing, monitoring, and mitigating risks that may have an impact on the study's quality or safety.

The decrease in the cost of clinical trials is a major factor that will drive the growth of the Risk-based Monitoring Market during the forecast period. Clinical trials are expensive during drug development, and it is estimated that risk-based monitoring can cut clinical trial costs by 30%. The risk-based monitoring process, in comparison to traditional studies, reduces clinical data error, which may drive the risk-based monitoring market growth during the forecast period. For example, the Association of Clinical Research Organizations (ACRO) is urging the FDA in 2019 to place even more emphasis on risk-based monitoring (RBM) of clinical trials, citing a recent study of its members that revealed a 16% reduction in major findings in audits among sites using this method. 

Read more @ https://cmiaspireblog.blogspot.com/2022/03/risk-based-monitoring-market-challenges.html

[hrexecutivebyashishbhalla]

Tweeted

hcltech: Get an in-depth understanding of risk-based monitoring (RBM) frameworks for #clinicaltrials, the impediments in enabling it, and next-gen #RBM strategy: https://t.co/SeIj9pLsAG #RiskBasedMonitoring

— Ashish Bhalla (@Ashish__Bhalla) August 8, 2019

[hrexecutivebyashishbhalla]

hcltech: Get an in-depth understanding of risk-based monitoring (RBM) frameworks for #clinicaltrials, the impediments in enabling it, and next-gen #RBM strategy: https://t.co/SeIj9pLsAG #RiskBasedMonitoring

hcltech: Get an in-depth understanding of risk-based monitoring (RBM) frameworks for #clinicaltrials, the impediments in enabling it, and next-gen #RBM strategy: https://t.co/SeIj9pLsAG #RiskBasedMonitoring

— Ashish Bhalla (@Ashish__Bhalla) August 8, 2019

from Twitter https://twitter.com/Ashish__Bhalla August 08, 2019 at 12:39AM via IFTTT